Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eleven Biotherapeutics Inc (NASDAQ:EBIO)

0.273
Delayed Data
As of 3:59pm ET
 +0.0031 / +1.15%
Today’s Change
0.25
Today|||52-Week Range
13.78
-90.93%
Year-to-Date
No recent news for Eleven Biotherapeutics Inc.

Today’s Trading

Previous close0.27
Today’s open0.27
Day’s range0.25 - 0.29
Volume633,800
Average volume (3 months)226,922
Market cap$5.3M
Dividend yield--
Data as of 3:59pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-66.90%
Earnings growth (this year)+36.14%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+68.14%
P/E ratioNM
Price/Sales77.56
Price/Book0.13

Competitors

 Today’s
change
Today’s
% change
CPHIChina Pharma Holding...+0.02+14.75%
CLRBCellectar Bioscience...-0.02-3.33%
ALXAAlexza Pharmaceutica...-0.01-1.96%
KTOVKitov Pharmaceutical...+0.05+2.15%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateMarch 2, 2016
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$2.2M
Annual profit (last year)-$34.2M
Net profit margin-1,522.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Abbie C. Celniker
Chief Financial &
Accounting Officer
John J. McCabe
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers